laboratori corp america lh
stori shift stock perform
maintain hold lh given view moder ep growth
due medicar rate cut contract chang headwind
previous known make meaning multipl expans earn upsid
surpris unlik said believ outlook beyond
better lh benefit acceler sector consolid continu
growth cro busi
guidanc summari adjust issu lh revenu
roughli line w/ consensu broad-bas strength covanc off-set
lower expect organ test volum lab segment despit in-lin adj revenu
ep miss consensu slightli vs even adjust lh lower
upper-end revenu guidanc lower midpoint ep
guidanc
issu face headwind dampen ep
growth revenue ep shortfal mostli due extran factor management
commentari modest ep growth underscor headwind compani
face believ make difficult argu multipl expans nt
management bake capit deploy ep growth commentari earn upsid
surpris hard come well street ep estim need come
current consensu view limit stock upsid next
month rais ep estim slightli reflect increas level
buyback given management commit deploy excess cash ex-acquisit
cro perform good overlook although lab
segment pressur overal result lh covanc strong result
overlook cro segment saw broad-bas growth across earli late-stag
develop launchpad effort chiltern synergi realiz yield
improv adj oper margin y/i
fundament outlook improv despit expect growth deceler
believ lh fundament mostli intact demand seem hold
issu management continu work drive oper effici across
compani medicar rate cut roll-off volum
present headwind expect re-acceler rev ep addit
expect lh pace pick especi independ hospital-own lab
increasingli struggl impact recent medicar rate cut
ep amort non-recur item
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
lh statement earn
page
pleas see import disclosur inform page report
 dollar million unless otherwis indic year end growth growth gross expens method incom expens pre-tax net incom lh averag dilut growth dilut ep growth growth size statementnet gross expens method incom expens pre-tax net incom lh
page
pleas see import disclosur inform page report
 dollar million unless otherwis indic -fiscal year end cash receiv current total current asset partnerships/equ asset total portion long-term expens total current incom total liab
page
pleas see import disclosur inform page report
 dollar million unless otherwis indic year end non-cash work flow oper invest flow invest issuanc issuanc financ flow financ exchang rate increas decreas ratiosstock compens expenditur a- -- -- -- -- -- -- -- -- -- -- -- pp -- -- -- -- -- -- -- -- -- -- -- lh
laboratori corp america
laboratori corpor america hold lead healthcar diagnost compani provid comprehens clinic laboratori servic
labcorp diagnost end-to-end drug develop support covanc drug develop
laboratori corp america
pt deriv appli lh lt price-to-earnings delta vs risk volum shift expect marketshar
gain independ region lab less expect
brian tanquilut certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
jason plagman certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
bryan ross cfa certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
case jefferi employe analyst respons coverag financi instrument discuss report receiv
compens base part overal perform firm includ invest bank incom seek updat research
appropri variou regul may prevent us asid certain industri report publish period basi larg major
report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within period
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate secur averag
secur price consist expect total return price appreci plu yield plu minu within period
under-perform rate secur averag secur price consist expect total return price appreci plu yield minu
less within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/
jefferi polici
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic secur regul
prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project opinion
invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil expect total
return next month price target base sever methodolog may includ restrict analys market
premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
page
pleas see import disclosur inform page report
